Comparative effectiveness of dabigatran, rivaroxaban, and edoxaban on cardiac and renal outcomes in Asian patients with atrial fibrillation: a propensity score-weighted analysis

Back

ESC Professional Premium Access

Comparative effectiveness of dabigatran, rivaroxaban, and edoxaban on cardiac and renal outcomes in Asian patients with atrial fibrillation: a propensity score-weighted analysis

Session: New perspectives in cardiology (2) - Drivers and modifiers of atrial fibrillation

Topic: Oral Anticoagulation

Speaker: Doctor J. Yeh (Taipei, TW)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Jong-Shiuan Yeh

Wang-Fang Medical Center, Taipei (Taiwan)

0 follower

10 more presentations in this session

Discussant - Drivers and modifiers of atrial fibrillation

Access

Impaired brachial flow-mediated dilatation as an evidence of endothelial dysfunction in patients with atrial fibrillation: a systematic review and meta-analysis

Speaker: Doctor W. Alghwyeen (Madaba, JO)

Access

Abstract

Slides

Prevalence of sinus node dysfunction in patients with implantable cardiac monitor for cryptogenetic stroke: a manifestation of atrial cardiomyopathy?

Speaker: Doctor P. Festa (Rome, IT)

Association of clonal hematopoesis and autonomic dysfunction with cardiovacular outcomes in atrial fibrillation

Speaker: Doctor P. Haemmerle (Basel, CH)

Osteosarcopenia and risk of atrial fibrillation from the UK Biobank

Speaker: Assistant Professor K. Lee (Seoul, KR)

Access the full session

New perspectives in cardiology (2) - Drivers and modifiers of atrial fibrillation

Speakers: Doctor J. Yeh, Doctor W. Alghwyeen, Doctor P. Festa, Doctor P. Haemmerle, Assistant Professor K. Lee

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources